Dendritic Cell Vaccination in Allogeneic Stem Cell Recipients: Induction of Human Cytomegalovirus (HCMV)–Specific Cytotoxic T Lymphocyte Responses Even in Patients Receiving a Transplant from an HCMV‐Seronegative Donor

Abstract
Vaccination with peptide-loaded dendritic cells (DCs) has been shown to be potent immunostimulatory therapy for the management of serious infections.

This publication has 0 references indexed in Scilit: